Omada Health

Big news: Omada Health will participate in Lilly’s Employer Connect program, adding another way to offer employers our GLP-1 Care Track alongside our existing pharmacy benefit manager and cash‑pay channels. That means more ways for employers to offer GLP‑1 medications with coordinated virtual care and lifestyle support. Omada also surveyed more than 3,000 people using or having used GLP‑1s and found that access alone isn’t enough—patients want help with nutrition, exercise, and what happens after the prescription. Proud to see Omada expanding responsible GLP‑1 access and support for both employers and members. Read more in the press release: https://lnkd.in/grk2qCeR

The benefit design conversation has shifted for employers. It’s not IF we should cover GLP-1s, but HOW. Thursday we announced that Omada Health will be an independent administrator in Eli Lilly and Company 's Employer Connect program, adding another way for employers to pair GLP-1 access with our GLP-1 Care Track for coordinated, virtual lifestyle support before, during, and after medication. Employers have options now. Between PBM solutions, Lilly’s Employer Connect, and Omada’s own GLP‑1 Flex Care, there’s a full menu of GLP‑1 support pathways to fit the needs of their population and budget—while pairing medication with behavior change, muscle preservation, and cardiometabolic risk reduction through Omada’s program. While we’ve been building this menu out, we’ve also been listening to patients. What we heard: for many, access is no longer the bottleneck. Support is. In a survey of over 3,000 GLP-1 patients from Omada, we found patients still face stigma, support gaps, and rising out‑of‑pocket costs that threaten continuity of care. Learn more: https://buff.ly/gkOng4a

If your employees are on GLP-1s and you're only tracking pounds lost, you're measuring the wrong thing. Up to 40% of GLP-1 weight loss can come from lean mass—not fat. That's muscle your members need for strength, metabolism, and long-term health. It's also a direct threat to the durability of your GLP-1 investment. Omada Health recently published a 12-week study of 245 adults on GLP-1s. Members in Omada's GLP-1 Care Track, on average, lost 1.8x more total weight and 2.1x more body fat while preserving muscle mass compared to a control group. They also reported meaningful improvements in mental health, physical functioning, and confidence in their ability to sustain weight loss. For employers and health plans, the implication is clear: the ROI of GLP-1s depends on the quality of the weight loss, not just the quantity. Programs that pair medication with strength-focused behavioral support protect the outcomes you're paying for—and the people behind them. Read the full analysis: https://lnkd.in/gWJdxe3b

What if GLP‑1s could change what you lose—not just how much? In a new 12‑week study from Omada Health demonstrated that, on average, members in the GLP-1 Care Track lost significantly more total weight and body fat than those on GLP‑1s alone, while preserving comparable muscle mass, compared to a control group. Not only are they improving their body composition, members also reported greater improvements in mood, anxiety symptoms, overall well‑being, physical functioning, and confidence in their ability to lose weight. Omada’s program delivers high-quality weight loss and supports both better body composition and an increase in quality of daily life. Learn more: https://lnkd.in/gkvvuKrN

Why am I so convinced Omada Health 's GLP‑1 prescribing capability is a game‑changer? Because it finally connects a breakthrough therapy to the kind of continuous care this space has been missing. Omada’s new GLP‑1 prescribing capability has the potential to connect that first prescription to wraparound care that supports members at every stage of treatment. That includes before they start a GLP‑1 all the way through provider visits and prescriptions, including between visits with lifestyle support, and even discontinuation and long‑term weight maintenance. We’ve designed this new GLP‑1 guided medication care option to help address two key challenges payers and employers face in obesity and weight management: ensuring appropriate medication use and managing costs effectively. Learn more: https://lnkd.in/gZQ59rEe

What if GLP‑1s could change what you lose—not just how much? In a new 12‑week study from Omada Health demonstrated that, on average, members in the GLP-1 Care Track lost significantly more total weight and body fat than those on GLP‑1s alone, while preserving comparable muscle mass, compared to a control group. Not only are they improving their body composition, members also reported greater improvements in mood, anxiety symptoms, overall well‑being, physical functioning, and confidence in their ability to lose weight. Omada’s program delivers high-quality weight loss and supports both better body composition and an increase in quality of daily life. Learn more: https://lnkd.in/g2XmCWea